Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Nivolumab
Related studies linked through entity extraction aliases.
CMP-001 in Combination With Nivolumab Compared to Nivolumab Monotherapy in Subjects With Advanced Melanoma
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Duvelisib in Combination With Nivolumab in Patients With Advanced Unresectable Melanoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Neoadjuvant Chemo-endocrine Therapy and Immunotherapy for Pre-menopausal Luminal B Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Study of Pharmacokinetic, Safety, Immunogenicity and Efficacy of CMAB819 and Nivolumab in R/M HNSCC
- Status
- TERMINATED
- Phase
- PHASE1
Feasibility and Efficacy of Perioperative Nivolumab With or Without Relatlimab for Patients With Potentially Resectable Hepatocellular Carcinoma (HCC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Safety and Efficacy in Participants With Metastatic BRAF-mutant Melanoma Treated With Encorafenib With and Without Binimetinib in Combination With Nivolumab and Low-dose Ipilimuma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Duvelisib and Nivolumab for the Treatment of Stage IIB-IVB Mycosis Fungoides and Sezary Syndrome
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Trying to Find the Correct Length of Treatment With Immune Checkpoint Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Rucaparib and Nivolumab in People With Leiomyosarcoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Relatlimab Plus Nivolumab in Combination With Chemotherapy vs. Nivolumab in Combination With Chemotherapy as First Line Treatment for Participants With Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trial of Chemotherapy, Oregovomab and Nivolumab in Patients With Epithelial Cancer of Ovarian, Tubal or Peritoneal Origin
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Neo-adjuvant Nivolumab or Nivolumab With Ipilimumab in Advanced Cutaneous Squamous Cell Carcinoma Prior to Surgery
- Status
- COMPLETED
- Phase
- PHASE2
PANFIRE-3 Trial: Assessing Safety and Efficacy of Irreversible Electroporation (IRE) + Nivolumab + CpG for Metastatic Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
Concurrent Nivolumab and External Beam Radiation Therapy for Patients With Advanced HCC
- Status
- COMPLETED
- Phase
- PHASE2
T-cell Therapy in Combination With Nivolumab, Relatlimab and Ipilimumab for Patients With Metastatic Ovarian Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of CG0070 Combined With Nivolumab in Cisplatin Ineligible Patients With MIBC
- Status
- COMPLETED
- Phase
- PHASE1
Immune Checkpoint Inhibition With Lurbinectedin Relapsed/Recurrent SCLC
- Status
- TERMINATED
- Phase
- PHASE1
Testing the Addition of Lenalidomide and Nivolumab to the Usual Treatment for Primary CNS Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
Surgical Nivolumab And Ipilimumab For Recurrent GBM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1